Overview

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The study is being conducted to compare the effect of standard treatment (target LDL-C level: <120 mg/dL (JASGL 2007 target level)) and intensive treatment (target LDL-C level: <70 mg/dL) in the prevention of major adverse cardiac events (MACE) in hypercholesterolemia patients with concomitant type 2 diabetes and hypertension.

Phase:

N/A

Details

Lead Sponsor:

Positive Trial Group

Treatments:

Pravastatin
Rosuvastatin Calcium